High-Fiber Diet Reduces Colorectal Adenoma Risk

Share this content:
High-Fiber Diet Reduces Colorectal Adenoma Risk
High-Fiber Diet Reduces Colorectal Adenoma Risk

(HealthDay News) — There is a significant inverse relationship between total dietary fiber intake and risk of colorectal adenoma (CRA), according to research published in the March issue of Gastroenterology.

Qiwen Ben, MD, of the Shanghai Jiaotong University in China, and colleagues conducted a meta-analysis of 20 case-control and cohort studies, involving 10,948 subjects with CRA. The researchers sought to assess the association between dietary fiber intake and risk of CRA.

"Reports on the association between dietary fiber intake and risk of CRA, the precursor of colorectal cancer, have been inconsistent. We conducted a meta-analysis of case-control and cohort studies to analyze this association," they wrote.

RELATED: Gastrointestinal Cancers Resource Center

The researchers observed associations between high total dietary fiber intake and reduced risk of CRA in a high-intake versus low-intake analysis (summary relative risk [SRR], 0.72; 95% confidence interval [CI], 0.63 to 0.83) and in a per 10 g/day-increase in fiber intake in a dose-response model (SRR, 0.91; 95% CI, 0.87 to 0.95).

For high intake versus low intake of fiber, subgroup analyses showed SRRs of 0.84 for fruit fiber (95% CI, 0.76 to 0.94), 0.93 for vegetable fiber (95% CI, 0.84 to 1.04), and 0.76 for cereal fiber (95% CI, 0.62 to 0.92).

"The results of this meta-analysis support the hypothesis that dietary fiber intake is associated inversely with the risk of CRA," the researchers wrote.


  1. Ben Q, Sun Y, Chai R, et al. Dietary Fiber Intake Reduces Risk for Colorectal Adenoma: A Meta-analysis. Gastroenterology. 2014; 146(3):689-699.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs